Our Services

Experts in growth

Corporate Finance

Providing trusted industry advice tailored to clients' individual needs.

Equity Capital Markets & Corporate Broking

Offering a fully rounded service to develop corporate clients' share ownership with new and existing institutional investors and private client brokers.

Mergers & Acquisitions

Delivering certainty on strategic M&A and financial advisory services.

Research

Our analysts are genuine enthusiasts and experts within their fields, dedicated to delivering concise, insightful research, to help companies and investors grow.

Sales

An essential link between company management and the investment market, with excellent relationships with top UK institutions and private client brokers.

Sales Trading & Market Making

An integral part of finnCap's service, gathering market intelligence to monitor flows and understand share price movements

Investment Companies

Building key relationships and delivering strategic advice for growth.

Private Fundraising

Raising capital for ambitious private growth and scale-up companies.

Sell-Side Advisory

The UK’s award-winning, leading sell side M&A advisory team at Cavendish Corporate Finance.

Buy-Side Advisory

Our track record of representing companies on the sell-side of acquisitions gives us a unique insight into providing tactical buy-side advice.

Debt Advisory

We speak the language of the capital providers to provide and help leaders access the ideal debt solutions for positive growth.

Dual-Track

Introducing our uniquely positioned team that advises and promotes the stories of private companies considering an exit, running the processes of IPO or sale in parallel.

A proactive approach to maintaining market interest in our corporate clients

Evgen Pharma Plc

Sector: Life Sciences
£5m Oversubscribed placing
April 2019

Independent Oil & Gas plc

Sector: Energy
£16.6m Fundraising & Open offer
April 2019

PPHE Hotel Group Ltd

Sector: Consumer
£149m Block trade
March 2019

Surface Transforms plc

Sector: Industrials
£1.9m Placing
March 2019